Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 06, 2014 07:24 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Acquires Exclusive Option to License Intellectual Property for Use of MANF and CDNF to Treat Antibiotic-Induced Ototoxicity

SAN FRANCISCO, March 6, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and...
March 03, 2014 12:00 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Outlines MANF Research Collaboration Strategy

SAN FRANCISCO, March 3, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and...
February 24, 2014 07:12 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Strengthens Management Team With Key Additions in Business Development and Regulatory Affairs

SAN FRANCISCO, Feb. 24, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB: AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and...
February 18, 2014 06:00 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Bioscience Holdings Announces $3M Solicitation of Previously Issued Warrants

SAN FRANCISCO, Feb. 18, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and...
February 06, 2014 09:00 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus to Present at 16th Annual BIO CEO & Investor Conference

SAN FRANCISCO, Feb. 6, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics...
January 29, 2014 07:30 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Establishes LymPro Research Collaboration With Boston University School of Medicine

SAN FRANCISCO, Jan. 29, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and...
January 27, 2014 22:37 ET | Source: Amarantus BioScience Holdings, Inc.

ESPN's Andrew Brandt Final Addition to #C4CT Concussion Awareness Summit

Final logistics set for pioneering conference during Super Bowl week featuring NFL Network's Andrea Kremer and more than 15 professional athletes including Jeremy Shockey, Carl Eller and Clinton...
January 21, 2014 12:49 ET | Source: Amarantus BioScience Holdings, Inc.

Clinton Portis, Jeremy Shockey, Dr. Robert Stern and NFL Network's Andrea Kremer Join #C4CT Concussion Awareness Summit at the United Nations During Super Bowl Week

NEW YORK, Jan. 21, 2014 (GLOBE NEWSWIRE) -- Amarantus BioScience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics...
January 15, 2014 10:00 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Founders Gerald and Dr. John Commissiong Selected as Black Money's "50 Most Important African-Americans in Technology"

SAN FRANCISCO, Jan. 15, 2014 (GLOBE NEWSWIRE) -- Amarantus BioScience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the development of novel diagnostics and therapeutics related to...
January 14, 2014 06:00 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus In-Licenses Levadopa-Induced Dyskinesia Phase 2b-Ready Eltoprazine From PGI Drug Discovery

SAN FRANCISCO, Jan. 14, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and...